WRIGHT MEDICAL GROUP N.V. (NASDAQ:TRNX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.
WRIGHT MEDICAL GROUP N.V. (NASDAQ:TRNX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 22, 2017, Sean D. Carney submitted his resignation as a member of the Board of Directors of Wright Medical Group N.V. (the “Company”), effective April 30, 2017. Mr. Carney’s decision to resign as a member of the Board of Directors did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
About WRIGHT MEDICAL GROUP N.V. (NASDAQ:TRNX)
Wright Medical Group N.V. is a medical device company. The Company is focused on extremities and biologics products. The Company’s segments include U.S. Lower Extremities & Biologics, U.S. Upper Extremities and International Extremities & Biologics. Its product portfolio consists of product categories, such as Upper extremities, which includes joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; Lower extremities, which includes joint implants and bone fixation devices for the foot and ankle; Biologics, which includes products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth, and Sports medicine and other, which includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries and other ancillary products. WRIGHT MEDICAL GROUP N.V. (NASDAQ:TRNX) Recent Trading Information
WRIGHT MEDICAL GROUP N.V. (NASDAQ:TRNX) closed its last trading session 00.00 at 20.67 with shares trading hands.
Wright Medical Group N.V. is a medical device company. The Company is focused on extremities and biologics products. The Company’s segments include U.S. Lower Extremities & Biologics, U.S. Upper Extremities and International Extremities & Biologics. Its product portfolio consists of product categories, such as Upper extremities, which includes joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; Lower extremities, which includes joint implants and bone fixation devices for the foot and ankle; Biologics, which includes products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth, and Sports medicine and other, which includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries and other ancillary products. WRIGHT MEDICAL GROUP N.V. (NASDAQ:TRNX) Recent Trading Information
WRIGHT MEDICAL GROUP N.V. (NASDAQ:TRNX) closed its last trading session 00.00 at 20.67 with shares trading hands.